Deal Announcements

Femta Pharma Gets Additional VC Funding

Wednesday, July 14, 2010 5:34:00 AM PDT | VentureDeal Staff

San Diego, California  --  Femta Pharmaceuticals has secured $2.2 million in new venture capital investment, according to an SEC regulatory filing.

Femta is developing therapeutic monoclonal antibodies for the treatment of various disease states.

Investors in the funding were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1